Find Research Projects

Search results

• A Phase III Randomized, Placebo-Controlled Clinical Tria

  Young, J. H.

  MERCK AND CO INC

  6/11/14 → 12/31/17

  Project: Research project

• A Phase III Randomized, Placebo Controlled, Double Blind

  Greeno, E. W.

  BAYER HEALTHCARE PHARMACEUTICALS

  10/13/09 → 10/31/15

  Project: Research project

• A Phase III Randomized, Multicenter, two arm, open label

  Yee, D.

  Genentech Inc.

  7/20/11 → 6/30/16

  Project: Research project

• A PHASE III RANDOMIZED, DOUBLE-BLIND,PLACEBO-CONTROLLED TRIAL TO EVALUATETHE EFFICACY AND SAFETY OF PRM-151 INPATIENTS WITH IDIOPATHIC PULMONARYFIBROSIS

  Kim, H. J.

  HOFFMANN-LA ROCHE PHARMACEUTICALS

  9/15/20 → 9/15/23

  Project: Research project

• A Phase III Randomized, double blind, pacebo-controlled

  Greeno, E. W.

  BAYER HEALTHCARE PHARMACEUTICALS

  5/20/08 → 9/30/14

  Project: Research project

• A PHASE III Open-Label Extension Study to Evaluate Long-termSafety and Efficacy Of PRM-151 In Patients with IdiopathicPulmonary Fibrosis (IPF)

  Kim, H. J.

  HOFFMANN-LA ROCHE PHARMACEUTICALS

  9/15/20 → 9/15/25

  Project: Research project

• A Phase III Open Label, Randomized, 2 Arm Study of Ixabe

  Carson, L. F.

  BRISTOL-MYERS SQUIBB PHARM RES

  6/30/09 → 6/30/13

  Project: Research project

• A Phase III Open-Label, Multi-Centre, Randomised Study Comparing NUC-1031 plus Cisplatin to Gemcitabine plus Cisplatin in Patients with Previously Untreated Locally Advanced orMetastatic Biliary Tract Cancer

  Greeno, E. W.

  NUCANA, INC

  12/12/19 → 12/31/24

  Project: Research project

• A Phase II International Multi-center Open label Proof o

  Argenta, P. A.

  Nexus Oncology

  9/1/10 → 8/11/11

  Project: Research project

• A Phase II International Multi-center Open label Proof o

  Argenta, P. A.

  Ipsen Innovation

  9/1/10 → 9/30/13

  Project: Research project

• A Phase III Multi-center Randomized Trial Comparing Tacr

  Bachanova, V.

  Dana-Farber Cancer Institute

  4/6/10 → 6/30/13

  Project: Research project

• A phase III multicenter randomized study of atezolizumab

  Geller, M. A.

  Genentech Inc.

  6/1/17 → 3/31/25

  Project: Research project

• A Phase III Multicenter, Randomized, Double-Blind Placeb

  Dykstra, D. D.

  BIOMEASURE INC

  1/23/06 → 9/30/07

  Project: Research project

• A Phase IIIb, multi-center, double-blind, placebo-contro

  Shepela, C.

  Pharmaceutical Product Development, Inc.

  8/10/06 → 12/31/08

  Project: Research project

• A Phase III, Randomized, Placebo-controlled, Double-blin

  Warlick, C. A.

  AstraZeneca

  7/1/09 → 12/31/11

  Project: Research project

• A Phase III, Randomized, Open-label, Controlled, Multi-C

  Gupta, S.

  AstraZeneca

  11/15/15 → 4/1/19

  Project: Research project

• A Phase III, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, Multicenter Study of theSafety and Efficacy of OT-101 (Atropine Sulfate 0.01%) in Treating the Progression of Myopia in PediatricSubjects

  Areaux, R.

  OCUMENSION THERAPEUTICS LTD

  3/1/21 → 2/28/26

  Project: Research project

• A Phase III, Randomized, Double-blind Comparison of Oral

  Dunitz, J. M.

  Duke University Medical Center

  10/15/03 → 3/12/08

  Project: Research project

• A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP,MULTICENTER, 52-WEEK EFFICACY AND SAFETY STUDY OF RO5285119 IN ADULTS WITH AUTISMSPECTRUM DISORDERS (ASD) WITH A 2-YEAR OPEN LABEL EXTENSION

  Jacob, S.

  HOFFMANN-LA ROCHE PHARMACEUTICALS

  4/11/18 → 4/30/23

  Project: Research project

• A Phase III, Randomized, Double-Blind, Placebo-Controlle

  Himes, J. H.

  Altus Pharmaceuticals Inc.

  4/1/07 → 12/31/08

  Project: Research project

• A Phase III, Randomized, Double-Blind, Placebo-Controlle

  Apostolidou, I.

  HOSPIRA WORLDWIDE INC

  8/1/07 → 11/30/07

  Project: Research project

• A Phase III, Randomized, Double-Blind, Placebo-controlle

  Warlick, C. A.

  AstraZeneca

  7/1/09 → 12/31/11

  Project: Research project

• A Phase III, Open Label Study to Evaluate the Safety and

  Warlick, C. A. & Konety, B. R.

  FKD THERAPIES OY

  9/15/16 → 9/14/22

  Project: Research project

• A PHASE III, OPEN-LABEL, RANDOMIZED STUDY OF ATEZOLIZUMA

  Patel, M. R.

  Genentech Inc.

  2/1/16 → 12/31/20

  Project: Research project

• A Phase III, Open-Label, Randomized, Parallel Group Study to Evaluate the Efficacy and Safety ofIntrapleural Administration of Adenovirus-Delivered Interferon Alpha-2b (rAd-IFN) in Combination withCelecoxib and Gemcitabine in Patients with Malignant P

  Kratzke, R. A.

  TRIZELL, LTD

  1/1/19 → 12/30/23

  Project: Research project

• A Phase III, Open-label, Randomized, Multi-center Study

  Jha, G.

  CEL-SCI CORPORATION

  12/6/13 → 11/30/18

  Project: Research project

• A Phase III, Open Label, Randomized, Controlled, Multi-c

  Potter, D. A.

  AstraZeneca

  6/1/14 → 6/30/19

  Project: Research project

• A Phase III, Open-Label, Multicenter, Randomized Study t

  Patel, M. R.

  Genentech Inc.

  11/20/13 → 12/31/20

  Project: Research project

• A Phase III, Open-label, Follow-on Study of Multiple Cou

  Billings, J. L.

  Gilead Sciences, Inc.

  8/1/05 → 7/31/08

  Project: Research project

• A Phase III, multicentre, randomized, parallel-group

  Carpenter, A.

  Genentech Inc.

  1/1/11 → 12/31/23

  Project: Research project

• A Phase III, multicenter placebo-controlled, randomized,

  Khoruts, A.

  Duke University

  6/8/07 → 12/31/10

  Project: Research project

• A Phase III, Multicenter, randomized, visual,assessor-masked, active-comparator study of the efficacy,safety, and pharmacokinetics of the port delivery system with Ranibizumab in patients with neovascularage-related macular degeneration.

  Montezuma, S. R. & Koozekanani, D.

  Genentech Inc.

  10/31/18 → 12/31/19

  Project: Research project

• A Phase III, Multicenter, Randomized, Placebo-Controlled

  Yee, D.

  Fairview Health Services

  4/19/06 → 2/28/08

  Project: Research project

• A Phase III, Multicenter, Randomized, Parallel Group, Double Blind, Double Dummy, Active Controlled Study of Evobrutinib Compared with Teriflunomide, in Participants with Relapsing Multiple Sclerosis to Evaluate Efficacy and Safety

  Carpenter, A.

  EMD Serono, Inc.

  3/1/21 → 2/28/27

  Project: Research project

• A Phase III, multi-center, placebo-controlled, randomize

  Khoruts, A.

  Duke University

  6/8/07 → 12/31/10

  Project: Research project

• A Phase III, International, Randomized, Controlled Study

  Warlick, E. D.

  ONCONOVA THERAPEUTICS, INC.

  12/31/15 → 7/1/21

  Project: Research project

• A Phase III, Double-Blind, Randomized Study to Evaluate

  Young, J. H.

  Astellas Pharma US, Inc.

  7/20/11 → 12/31/14

  Project: Research project

• A Phase III, Double Blind, Randomized Study to Evaluate

  Young, J. H.

  Astellas Pharma US, Inc.

  6/13/11 → 12/31/14

  Project: Research project

• A phase III, double-blind, randomized placebo-controlled

  Duprez, D.

  HOFFMANN-LA ROCHE PHARMACEUTICALS

  7/7/08 → 6/30/13

  Project: Research project

• A Phase III, double-blind, randomized controlled, multi-

  Downs, L. S.

  GlaxoSmithKline

  9/7/04 → 12/31/09

  Project: Research project

• A Phase III, Double-Blind, Randomized, Placebo-Controlle

  Allen, J. A.

  ViroMed Co., Ltd.

  3/1/16 → 12/31/19

  Project: Research project

• A phase III, double-blind, placebo-controlled study of V

  Rudrapatna, V. K.

  HOFFMANN-LA ROCHE PHARMACEUTICALS

  10/30/12 → 12/31/15

  Project: Research project

• A Phase II Exploratory, Randomized, Placebo-Controlled

  Konety, B. R., Warlick, C. A. & Weight, C. J.

  University of Wisconsin-Madison

  9/24/13 → 9/23/18

  Project: Research project

• A Phase II Evaluation of Topical NSAIDs in Eyes with Non

  Koozekanani, D.

  Jaeb Center for Health Research

  5/1/11 → 12/31/13

  Project: Research project

• A Phase II Clinical Trial to Study the Efficacy and Safe

  Zabell, J. R., Gupta, S. & Konety, B. R.

  MERCK

  3/1/16 → 1/30/24

  Project: Research project

• A Phase IIB Randomized, Placebo-Controlled Trial of Piog

  Ondrey, F. G.

  University of Wisconsin-Madison

  9/1/10 → 9/15/14

  Project: Research project

• A phase IIB,double-blind,randomized,Placebo-controlled,

  Duprez, D.

  HOFFMANN-LA ROCHE PHARMACEUTICALS

  3/28/08 → 3/27/11

  Project: Research project

• A Phase IIA Exploratory, Randomized, Placebocontrolled T

  Konety, B. R.

  University of Wisconsin-Madison

  2/1/13 → 2/28/14

  Project: Research project

• A Phase IIa Cancer Prevention Trial of the PPAR Gamma Ag

  Ondrey, F. G.

  NIH NATIONAL CANCER INSTITUTE (NCI)

  9/30/01 → 9/29/07

  Project: Research project

• A Phase IIa, Double-Blind, Randomized, Intracohort Placebo-Controlled, Multicenter Study to Evaluate theSafety, Tolerability and Preliminary Efficacy of EHP-101 in Patients with Diffuse Cutaneous SystemicSclerosis

  Molitor, J. A.

  EMERALD HEALTH PHARMACEUTICALS, INC

  10/6/20 → 10/31/25

  Project: Research project